Results 121 to 130 of about 130,251 (209)

Anti-tumor efficacy of RAF/MEK inhibitor VS6766 in KRAS-mutated colorectal cancer cells. [PDF]

Cancer Chemother Pharmacol
Zhu H, Yan G, Ma J, Zhang B, Yan Y, Zhu L, Dong R, Lin N, Tan B.   +8 more
europepmc   +1 more source

Molecular Evidence Supporting MEK Inhibitor Therapy in NF1 Pseudarthrosis. [PDF]

J Bone Joint Surg Am
Paria N, Oxendine I, Podeszwa D, Wassell M, Cornelia R, Wise CA, Rios JJ.   +6 more
europepmc   +1 more source

Sensitivity to immune checkpoint inhibitors in BRAF/MEK inhibitor refractory melanoma. [PDF]

J Immunother Cancer
Patel RP, Lim LRJ, Saleh R, Schenk D, Lee MK, Lelliott E, Rao AD, Arabi S, Smith L, Trigos AS, Haynes N, McArthur GA, Sheppard KE.   +12 more
europepmc   +1 more source

Editorial expression of concern: ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells. [PDF]

J Exp Clin Cancer Res
Zhou S, Xia H, Xu H, Tang Q, Nie Y, Gong QY, Bi F.   +6 more
europepmc   +1 more source

Co-operative epigenetic remodelling by Setd2 deficiency and Kras mutation drives juvenile myelomonocytic leukaemia development and MEK inhibitor sensitivity. [PDF]

Br J Haematol
Munyurangabo G, Zhang L, Zhou Y, Zhang P, Yu X, Qu D, Yang D, Ren X, Liu H, Wu Y, Kong G, Yang Y.   +11 more
europepmc   +1 more source

System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells. [PDF]

Cell Rep Med
Medina EF, Farmaki E, Griffiths JI, Bild AH, Nath A.   +4 more
europepmc   +1 more source

Rapid response to BRAF/MEK inhibitor therapy within 2 weeks for high-grade glioma with leptomeningeal metastasis: illustrative case. [PDF]

J Neurosurg Case Lessons
Kawaguchi Y, Hana T, Hasegawa H, Murakami C, Higashi M, Hanakita S.   +5 more
europepmc   +1 more source

Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS-mutated colorectal cancer. [PDF]

Ther Adv Med Oncol
Ghosh S, Fan F, Powell R, Park YS, Stephan C, Kopetz ES, Ellis LM, Bhattacharya R.   +7 more
europepmc   +1 more source

Prospects of BRAF/MEK Inhibitor Therapy in Papillary Craniopharyngiomas with the BRAF V600E Mutation: A Scoping Review. [PDF]

Neurol Med Chir (Tokyo)
Fujio S, Ilmansyah R, Makino R, Juratli TA, Sugata J, Bakhtiar Y, Hanaya R.   +6 more
europepmc   +1 more source

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents [PDF]

, 2017
Abraham, Christopher, Acharya, Sahaja, Chicoine, Michael, Dowling, Joshua, Dunn, Gavin, Huang, Jiayi, Keller, Jesse, Leuthardt, Eric, Mahmood, Mustafaa, Mullen, Daniel, Perkins, Stephanie M, Rich, Keith, Robinson, Clifford G, Tsien, Christina I, Yang, Deshan   +14 more
core   +2 more sources